Sbir topic 088, direct-to-phase II, closure devices for transcaval access to the abdominal aorta
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN268201500012C
- Awardee
-
Transmural Systems LLC UEI NVTWAUS1JEH5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,000,000
Award facts
- Opportunity
-
- PHS20151 Solicitation number
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Award Notice · Posted Jul 31, 2014
- Contract value 100% obligated
- $2,999,999.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Andover, MA 01810, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,000,000 |
About this award
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for the development of a "Closure Devices for Transcaval Access to the Abdominal Aorta" under SBIR Topic 088. The contract has a ceiling value of $2,999,999.98 and was awarded on a firm fixed-price basis. Transmural Systems has previously received SBIR and grant funding from NHLBI for the research and development of various cardiovascular devices, including a Transcatheter Cavopulmonary Bypass Endograft. This current contract supports the continued development of Transmural Systems' medical devices, with the goal of obtaining FDA approval for expanded clinical trials and commercialization.
Quick answers
Who was awarded contract HHSN268201500012C?
HHSN268201500012C was awarded to Transmural Systems LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 10, 2015.
How much is contract HHSN268201500012C worth?
The government has obligated $3,000,000 on HHSN268201500012C.
Was contract HHSN268201500012C competed?
The extent of competition for HHSN268201500012C was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award